Today, the European Commission concluded talks with Valneva to secure a new potential vaccine against COVID-19.
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
Read on to find out more about Oils By Simpson, Kim Schleppegrell Skaue, and their joint mission to encourage natural medicine use worldwide.
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.
Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.
SACIDS Africa Centre of Excellence for Infectious Diseases trains young African scientists in research on global health issues: An example of a PhD Student Research on antimicrobial resistance (AMR).
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.
Roxane Feller, Secretary General of AnimalhealthEurope, sheds light on One Health – the only way forward that includes comment on veterinary medicines.
Elixinol, Merges Water-Soluble Technology with THC-Free CBD in a New Range of CBD Blended Tinctures.
Dr Deborah Lee from Dr Fox Online Pharmacy sheds light on the role of plants in drugs and medicines in this absorbing analysis.
Andreas Met, COO, Compliance and Director at Halo Labs highlights how the use of medical cannabis is on the rise in the UK and could offer relief to many NHS patients.
Dr Charlie Easmon from Your Excellent Health Service gives a medical professional’s opinion on medical marijuana in the UK, including comment on hemp, CBD and THC.
Here, Robin Emerson, Head of CSR at Brains Bioceutical charts the priorities for cannabis research.
Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
Rex Clements, CEO at Centrient Pharmaceuticals, discusses how the upcoming EU Pharma Strategy can prevent shortages and strengthen Europe’s manufacturing base, especially for antibiotics.
OCD symptoms could be eased by atleast half in the short-term, according to a new study published in the Journal of Affective Disorders.
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains CBG (cannabigerol), a “new” cannabinoid with vast potential in cannabis research.
In early 2016, I had reached a point in life where I needed to make a life-changing decision: Read the Savage Cabbage journey on OAG.